1: Vartolomei MD, Remzi M, Fajkovic H, Shariat SF. Robot-Assisted Partial Nephrectomy Mid-Term Oncologic Outcomes: A Systematic Review. J Clin Med. 2022 Oct 19;11(20):6165. doi: 10.3390/jcm11206165. PMID: 36294486; PMCID: PMC9605111.

2: Contieri R, Hurle R, Paciotti M, Casale P, Saita A, Porpiglia F, Fiori C, Barone B, Crocetto F, Lucarelli G, Busetto GM, Del Giudice F, Maggi M, Cantiello F, Damiano R, Borghesi M, Bove P, Bertolo R, Papalia R, Mari A, Luzzago S, Mistretta FA, Soria F, Gontero P, Marchioni M, LA Civita E, Terracciano D, Russo GI, Schips L, Perdonà S, Mirone V, Tataru OS, Musi G, Vartolomei MD, Autorino R, Montanari E, DE Cobelli O, Ferro M. Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG. Minerva Urol Nephrol. 2022 Oct 5. doi: 10.23736/S2724-6051.22.04953-9. Epub ahead of print. PMID: 36197700.

3: Ferro M, de Cobelli O, Musi G, Del Giudice F, Carrieri G, Busetto GM, Falagario UG, Sciarra A, Maggi M, Crocetto F, Barone B, Caputo VF, Marchioni M, Lucarelli G, Imbimbo C, Mistretta FA, Luzzago S, Vartolomei MD, Cormio L, Autorino R, Tătaru OS. Radiomics in prostate cancer: an up-to-date review. Ther Adv Urol. 2022 Jul 4;14:17562872221109020. doi: 10.1177/17562872221109020. PMID: 35814914; PMCID: PMC9260602.

4: Vartolomei MD, Ferro M, Roth B, Teoh JY, Gontero P, Shariat SF. Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update. Curr Opin Urol. 2022 Sep 1;32(5):575-583. doi:10.1097/MOU.0000000000001010. Epub 2022 Jun 24. PMID: 35749398.

5: Ferro M, Barone B, Crocetto F, Lucarelli G, Busetto GM, Del Giudice F, Maggi M, Crocerossa F, Cantiello F, Damiano R, Borghesi M, Bove PL, Papalia R, Mari A, Luzzago S, Soria F, Marchioni M, La Civita E, Terracciano D, Mistretta FA, Piccinelli M, Marmiroli A, Russo GI, Schips L, Hurle R, Contieri R, Perdonà S, Del Prete P, Mirone V, Tataru OS, Musi G, Montanari E, de Cobelli O, Vartolomei MD. Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer. Urol Oncol. 2022 Nov;40(11):490.e13-490.e20. doi: 10.1016/j.urolonc.2022.05.016. Epub 2022 Jun 5. PMID: 35676172.

6: Ferro M, Tătaru OS, Musi G, Lucarelli G, Abu Farhan AR, Cantiello F, Damiano R, Hurle R, Contieri R, Busetto GM, Carrieri G, Cormio L, Del Giudice F, Sciarra A, Perdonà S, Borghesi M, Terrone C, La Civita E, Bove P, Autorino R, Muto M, Crisan N, Marchioni M, Schips L, Soria F, Terracciano D, Papalia R, Crocetto F, Barone B, Russo GI, Luzzago S, Ludovico GM, Vartolomei MD, Mistretta FA, Mirone V, de Cobelli O. Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy. Diagnostics (Basel). 2022 Feb 25;12(3):586. doi: 10.3390/diagnostics12030586. PMID: 35328139; PMCID: PMC8947693.

7: Vartolomei L, Cotruș A, Tătaru SO, Vartolomei MD, Man A, Ferro M, Stanciu C, Sin AI, Shariat SF. Lower urinary tract symptoms are associated with clinically relevant depression, anxiety, and stress symptoms. Aging Male. 2022 Dec;25(1):62-66. doi: 10.1080/13685538.2022.2040981. PMID: 35179090.

8: Ferro M, Chiujdea S, Musi G, Lucarelli G, Del Giudice F, Hurle R, Damiano R, Cantiello F, Mari A, Minervini A, Busetto GM, Carrieri G, Crocetto F, Barone B, Caputo VF, Cormio L, Ditonno P, Sciarra A, Terracciano D, Cioffi A, Luzzago S, Piccinelli M, Mistretta FA, Vartolomei MD, de Cobelli O. Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis. Clin Genitourin Cancer. 2022 Apr;20(2):e166-e172. doi: 10.1016/j.clgc.2021.12.005. Epub 2021 Dec 10. PMID: 35033480.

10: Balan D, Vartolomei MD, Magdás A, Balan-Bernstein N, Voidăzan ST, Mártha O. Inflammatory Markers and Thromboembolic Risk in Patients with Non-Muscle-Invasive Bladder Cancer. J Clin Med. 2021 Nov 12;10(22):5270. doi:10.3390/jcm10225270. PMID: 34830552; PMCID: PMC8617657.

11: Ferro M, Del Giudice F, Carrieri G, Busetto GM, Cormio L, Hurle R, Contieri R, Arcaniolo D, Sciarra A, Maggi M, Porpiglia F, Manfredi M, Fiori C, Antonelli A, Tafuri A, Bove P, Terrone C, Borghesi M, Costantini E, Iliano E, Montanari E, Boeri L, Russo GI, Madonia M, Tedde A, Veccia A, Simeone C, Liguori G, Trombetta C, Brunocilla E, Schiavina R, Dal Moro F, Racioppi M, Vartolomei MD, Longo N, Spirito L, Crocetto F, Cantiello F, Damiano R, Di Stasi SM, Marchioni M, Schips L, Parma P, Carmignani L, Conti A, Soria F, Gontero P, Barone B, Deho F, Zaffuto E, Papalia R, Scarpa RM, Pagliarulo V, Lucarelli G, Ditonno P, Botticelli FMG, Musi G, Catellani M, de Cobelli O. The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi- Institutional Cohort Analysis. Cancers (Basel). 2021 Oct 21;13(21):5276. doi: 10.3390/cancers13215276. PMID: 34771440; PMCID: PMC8582553.

12: Tătaru OS, Martha O, Crocetto F, Barone B, Voidazan S, Borda A, Sin A, Hutanu A, Loghin A, Sin I, Porav-Hodade D, Chibelean CB, Vartolomei L, Lucarelli G, Ferro M, Osan VG, Buonerba C, Vartolomei MD. Fascin-1 and its role as a serological marker in prostate cancer: a prospective case-control study. Future Sci OA. 2021 Jun 30;7(9):FSO745. doi: 10.2144/fsoa-2021-0051. PMID: 34737886; PMCID: PMC8558850.

13: Ferro M, de Cobelli O, Vartolomei MD, Lucarelli G, Crocetto F, Barone B, Sciarra A, Del Giudice F, Muto M, Maggi M, Carrieri G, Busetto GM, Falagario U, Terracciano D, Cormio L, Musi G, Tataru OS. Prostate Cancer Radiogenomics-From Imaging to Molecular Characterization. Int J Mol Sci. 2021 Sep 15;22(18):9971. doi: 10.3390/ijms22189971. PMID: 34576134; PMCID: PMC8465891.

14: Ferro M, Lucarelli G, de Cobelli O, Dolce P, Terracciano D, Musi G, Porreca A, Busetto GM, Del Giudice F, Soria F, Gontero P, Cantiello F, Damiano R, Crocerossa F, Abu Farhan AR, Autorino R, Vartolomei MD, Marchioni M, Mari A, Minervini A, Longo N, Celentano G, Chiancone F, Perdonà S, Del Prete P, Ditonno P, Battaglia M, Zamboni S, Antonelli A, Greco F, Russo GI, Hurle R, Crisan N, Manfredi M, Porpiglia F, Ribera D, De Placido P, Facchini S, Scafuri L, Verde A, Di Lorenzo G, Cosimato V, Luciano A, Caputo VF, Crocetto F, Buonerba C. A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy. Future Oncol. 2021 Oct;17(30):3987-3994. doi: 10.2217/fon-2020-1298. Epub 2021 Jul 19. PMID: 34278815.

15: Ferro M, Babă DF, de Cobelli O, Musi G, Lucarelli G, Terracciano D, Porreca A, Busetto GM, Del Giudice F, Soria F, Gontero P, Cantiello F, Damiano R, Rocco P, Scarpa RM, Abu Farhan AR, Autorino R, Brescia A, Marchioni M, Mari A, Minervini A, Longo N, Chiancone F, Perdona’ S, Barone B, Placido P, Catellani M, Bottero D, Ditonno P, Battaglia M, Zamboni S, Antonelli A, Greco F, Russo GI, Smelzo S, Hurle R, Crisan N, Manfredi M, Porpiglia F, Crocetto F, Buonerba C, Danilesco A, Vartolomei MD. Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy. Future Sci OA. 2021 Apr 20;7(7):FSO709. doi:10.2144/fsoa-2021-0008. PMID: 34258022; PMCID: PMC8256323.

16: Ferro M, Terracciano D, Musi G, de Cobelli O, Vartolomei MD, Damiano R, Cantiello F, Buonerba C, Morelli M, Mistretta FA, Luzzago S, Perdonà S, Del Prete P, Del Giudice F, Busetto GM, Porreca A, Autorino R, Manfredi M, Porpiglia F, Muto M, Loizzo D, Ditonno P, Battaglia M, Lucarelli G. Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies. Urol Int. 2022;106(1):75-82. doi:10.1159/000516680. Epub 2021 Jun 24. PMID: 34167120.

17: Ferro M, de Cobelli O, Musi G, Lucarelli G, Terracciano D, Pacella D, Muto T, Porreca A, Busetto GM, Del Giudice F, Soria F, Gontero P, Cantiello F, Damiano R, Crocerossa F, Farhan ARA, Autorino R, Vartolomei MD, Muto M, Marchioni M, Mari A, Scafuri L, Minervini A, Longo N, Chiancone F, Perdona S, De Placido P, Verde A, Catellani M, Luzzago S, Mistretta FA, Ditonno P, Caputo VF, Battaglia M, Zamboni S, Antonelli A, Greco F, Russo GI, Hurle R, Crisan N, Manfredi M, Porpiglia F, Di Lorenzo G, Crocetto F, Buonerba C. Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis. Front Oncol. 2021 May 11;11:651745. doi: 10.3389/fonc.2021.651745. PMID: 34046347; PMCID: PMC8144638.

18: Ferro M, Di Mauro M, Cimino S, Morgia G, Lucarelli G, Abu Farhan AR, Vartolomei MD, Porreca A, Cantiello F, Damiano R, Busetto GM, Del Giudice F, Hurle R, Perdonà S, Borghesi M, Bove P, Autorino R, Crisan N, Marchioni M, Schips L, Soria F, Mari A, Minervini A, Veccia A, Battaglia M, Terracciano D, Musi G, Cordima G, Muto M, Mirone V, de Cobelli O, Russo GI. Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer. Transl Androl Urol. 2021 Feb;10(2):626-635. doi: 10.21037/tau-20-1272. PMID: 33718065; PMCID: PMC7947442.

19: Tătaru OS, Vartolomei MD, Rassweiler JJ, Virgil O, Lucarelli G, Porpiglia F, Amparore D, Manfredi M, Carrieri G, Falagario U, Terracciano D, de Cobelli O, Busetto GM, Del Giudice F, Ferro M. Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives. Diagnostics (Basel). 2021 Feb 20;11(2):354. doi: 10.3390/diagnostics11020354. PMID: 33672608; PMCID: PMC7924061.

20: Ferro M, Marchioni M, Lucarelli G, Vartolomei MD, Soria F, Terracciano D, Mistretta FA, Luzzago S, Buonerba C, Cantiello F, Mari A, Minervini A, Veccia A, Antonelli A, Musi G, Hurle R, Busetto GM, Del Giudice F, Chung BI, Berardinelli F, Perdonà S, Del Prete P, Mirone V, Borghesi M, Porreca A, Bove P, Autorino R, Crisan N, Abu Farhan AR, Battaglia M, Ditonno P, Russo GI, Muto M, Damiano R, Manfredi M, Porpiglia F, DE Cobelli O, Schips L. Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicenter study. Minerva Urol Nephrol. 2021 Dec;73(6):796-802. doi: 10.23736/S2724-6051.20.04076-X. Epub 2021 Jan 13. PMID: 33439571.

21: Furrer MA, Grueter T, Bosshard P, Vartolomei MD, Kiss B, Thalmann GN, Roth B. Routine Preoperative Bone Scintigraphy Has Limited Impact on the Management of Patients with Invasive Bladder Cancer. Eur Urol Focus. 2021 Sep;7(5):1052-1060. doi: 10.1016/j.euf.2020.09.016. Epub 2020 Oct 12. PMID:33060038.

22: Ferro M, Lucarelli G, de Cobelli O, Vartolomei MD, Damiano R, Cantiello F, Crocerossa F, Perdonà S, Del Prete P, Cordima G, Musi G, Del Giudice F, Busetto GM, Chung BI, Porreca A, Ditonno P, Battaglia M, Terracciano D. Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies. World J Urol. 2021 Jun;39(6):1861-1867. doi: 10.1007/s00345-020-03368-9. Epub 2020 Jul 18. PMID: 32683462; PMCID: PMC8217017.

23: Ferro M, Katalin MO, Buonerba C, Marian R, Cantiello F, Musi G, Di Stasi S, Hurle R, Guazzoni G, Busetto GM, Del Giudice F, Perdonà S, Del Prete P, Mirone V, Borghesi M, Porreca A, Artibani W, Bove P, Lima E, Autorino R, Crisan N, Abu Farhan AR, Battaglia M, Ditonno P, Serretta V, Russo GI, Terracciano D, di Lorenzo G, Damiano R, Sonpavde G, Vartolomei MD, de Cobelli O, Lucarelli G. Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor. Urol Oncol. 2020 May;38(5):459-464. doi:10.1016/j.urolonc.2020.02.016. Epub 2020 Mar 12. PMID: 32173242.

24: Ferro M, De Cobelli O, Lucarelli G, Porreca A, Busetto GM, Cantiello F, Damiano R, Autorino R, Musi G, Vartolomei MD, Muto M, Terracciano D. Beyond PSA: The Role of Prostate Health Index (phi). Int J Mol Sci. 2020 Feb 11;21(4):1184. doi: 10.3390/ijms21041184. PMID: 32053990; PMCID: PMC7072791.

25: Stojkova Gafner E, Grüter T, Furrer MA, Bosshard P, Kiss B, Vartolomei MD, Roth B. A treatment strategy to help select patients who may not need secondary intervention to remove symptomatic ureteral stones after previous stenting. World J Urol. 2020 Nov;38(11):2955-2961. doi: 10.1007/s00345-020-03087-1. Epub 2020 Jan 20. PMID: 31960109.

26: Vartolomei L, Vartolomei MD, Shariat SF. Bladder Cancer: Depression, Anxiety, and Suicidality Among the Highest-risk Oncology Patients. Eur Urol Focus. 2020 Nov 15;6(6):1158-1161. doi: 10.1016/j.euf.2019.10.008. Epub 2019 Dec 11. PMID: 31836463.

27: Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Der Kwast TV, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, De Bari B, De Blok W, J L De Visschere P, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR, N’Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, J G Oyen W, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Van Der Heijden AG, Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Rivera FAV, Wiegel T, Wiklund P, Williams A, Zigeuner R, Horwich A. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort^†: Under the Auspices of the EAU-ESMO Guidelines Committees. Eur Urol. 2020 Feb;77(2):223-250. doi: 10.1016/j.eururo.2019.09.035. Epub 2019 Nov 19. Erratum in: Eur Urol. 2020 Jul;78(1):e48-e50. PMID: 31753752.

28: Horwich A, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Van Der Kwast T, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, De Bari B, DeBlok W, De Visschere PJL, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Carmen Mir M, Moschini M, Mostafid H, Müller AC, Müller CR, N’Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, Oyen WJG, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Vahr Lauridsen S, Valdagni R, Van Der Heijden AG, Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Vives Rivera FA, Wiegel T, Wiklund P, Williams A, Zigeuner R, Witjes JA. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†. Ann Oncol. 2019 Nov 1;30(11):1697-1727. doi: 10.1093/annonc/mdz296. PMID: 31740927; PMCID: PMC7360152.

29: Brad AB, Ferro M, Vartolomei MD, Tătaru S, Anton-Păduraru DT, Simion C, Martha O, Pricop C, Porreca A, Negru I. Particularities and Efficacy of Extracorporeal Shock Wave Lithotripsy in Children. Urol Int. 2019;103(3):318-325. doi: 10.1159/000502101. Epub 2019 Aug 6. PMID: 31387108.

30: Vartolomei MD, Iwata T, Roth B, Kimura S, Mathieu R, Ferro M, Shariat SF, Seitz C. Impact of alcohol consumption on the risk of developing bladder cancer: a systematic review and meta-analysis. World J Urol. 2019 Nov;37(11):2313-2324. doi: 10.1007/s00345-019-02825-4. Epub 2019 Jun 6. PMID: 31172281.

31: Cantiello F, Russo GI, Vartolomei MD, Farhan ARA, Terracciano D, Musi G, Lucarelli G, Di Stasi SM, Hurle R, Serretta V, Busetto GM, Scafuro C, Perdonà S, Borghesi M, Schiavina R, Cioffi A, De Berardinis E, Almeida GL, Bove P, Lima E, Ucciero G, Matei DV, Crisan N, Verze P, Battaglia M, Guazzoni G, Autorino R, Morgia G, Damiano R, de Cobelli O, Mirone V, Shariat SF, Ferro M. Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer. Eur Urol Oncol. 2018 Oct;1(5):403-410. doi: 10.1016/j.euo.2018.06.006. Epub 2018 Jul 13. PMID:31158079.

32: Vartolomei L, Shariat SF, Vartolomei MD. Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature. Eur Urol Oncol. 2018 Sep;1(4):283-291. doi: 10.1016/j.euo.2018.04.011. Epub 2018 May 15. PMID: 31100249.

33: Ferro M, Di Lorenzo G, Vartolomei MD, Bruzzese D, Cantiello F, Lucarelli G, Musi G, Di Stasi S, Hurle R, Guazzoni G, Busetto GM, Gabriele A, Del Giudice F, Damiano R, Perri F, Perdona S, Verze P, Borghesi M, Schiavina R, Almeida GL, Bove P, Lima E, Autorino R, Crisan N, Farhan ARA, Battaglia M, Russo GI, Ieluzzi V, Morgia G, De Placido P, Terracciano D, Cimmino A, Scafuri L, Mirone V, De Cobelli O, Shariat S, Sonpavde G, Buonerba C. Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor. World J Urol. 2020 Jan;38(1):143-150. doi: 10.1007/s00345-019-02754-2. Epub 2019 Apr 16. PMID: 30993426.

34: Lucarelli G, Loizzo D, Ferro M, Rutigliano M, Vartolomei MD, Cantiello F, Buonerba C, Di Lorenzo G, Terracciano D, De Cobelli O, Bettocchi C, Ditonno P, Battaglia M. Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update. Expert Rev Mol Diagn. 2019 May;19(5):377-387. doi: 10.1080/14737159.2019.1604223. Epub 2019 Apr 24. PMID: 30957583.

35: Roth B, Furrer MA, Giannakis I, Vartolomei MD, Boxler S, Wuethrich PY, Burkhard FC, Thalmann GN, Kiss B. Positive Pre-cystectomy Biopsies of the Prostatic Urethra or Bladder Neck Do Not Necessarily Preclude Orthotopic Bladder Substitution. J Urol. 2019 May;201(5):909-915. doi: 10.1097/JU.0000000000000034. PMID: 30694935.

36: Kimura S, D’ Andrea D, Soria F, Foerster B, Abufaraj M, Vartolomei MD, Iwata T, Karakiewicz PI, Rink M, Gust KM, Egawa S, Shariat SF. Prognostic value of modified Glasgow Prognostic Score in non-muscle-invasive bladder cancer. Urol Oncol. 2019 Mar;37(3):179.e19-179.e28. doi: 10.1016/j.urolonc.2018.11.005. Epub 2018 Dec 21. PMID: 30580906.

37: Stangl-Kremser J, D’Andrea D, Vartolomei M, Abufaraj M, Goldner G, Baltzer P, Shariat SF, Tamandl D. Prognostic value of nutritional indices and body composition parameters including sarcopenia in patients treated with radiotherapy for urothelial carcinoma of the bladder. Urol Oncol. 2019 Jun;37(6):372-379. doi: 10.1016/j.urolonc.2018.11.001. Epub 2018 Dec 18. PMID:30578161.

38: Vartolomei MD, D’Andrea D, Chade DC, Soria F, Kimura S, Foerster B, Abufaraj M, Mathieu R, Moschini M, Rouprêt M, Briganti A, Karakiewicz PI, Shariat SF. Role of serum cholinesterase in patients treated with salvage radical prostatectomy. Urol Oncol. 2019 Feb;37(2):123-129. doi: 10.1016/j.urolonc.2018.11.013. Epub 2018 Dec 3. PMID: 30522902.

39: Ferro M, Di Lorenzo G, de Cobelli O, Bruzzese D, Pignataro P, Borghesi M, Musi G, Vartolomei MD, Cosimato V, Serino A, Ieluzzi V, Terracciano D, Damiano R, Cantiello F, Mistretta FA, Muto M, Lucarelli G, De Placido P, Buonerba C. Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials. World J Urol. 2019 Jun;37(6):1049-1059. doi: 10.1007/s00345-018-2579-x. Epub 2018 Dec 5. PMID: 30519742.

40: Ferro M, Di Lorenzo G, Buonerba C, Lucarelli G, Russo GI, Cantiello F, Farhan ARA, Di Stasi S, Musi G, Hurle R, Vincenzo S, Busetto GM, De Berardinis E, Perdonà S, Borghesi M, Schiavina R, Almeida GL, Bove P, Lima E, Grimaldi G, Matei DV, Mistretta FA, Crisan N, Terracciano D, Paolo V, Battaglia M, Guazzoni G, Autorino R, Morgia G, Damiano R, Muto M, Rocca R, Mirone V, de Cobelli O, Vartolomei MD. Predictors of Residual T1 High Grade on Re-Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder Cancer. J Cancer. 2018 Oct 20;9(22):4250-4254. doi:10.7150/jca.26129. PMID: 30519326; PMCID: PMC6277616.

41: Gabriele C, Cantiello F, Nicastri A, Crocerossa F, Russo GI, Cicione A, Vartolomei MD, Ferro M, Morgia G, Lucarelli G, Cuda G, Damiano R, Gaspari M. High-throughput detection of low abundance sialylated glycoproteins in human serum by TiO₂ enrichment and targeted LC-MS/MS analysis: application to a prostate cancer sample set. Anal Bioanal Chem. 2019 Jan;411(3):755-763. doi: 10.1007/s00216-018-1497-5. Epub 2018 Nov 28. PMID: 30483857.

42: D’Andrea D, Soria F, Abufaraj M, Gust K, Foerster B, Vartolomei MD, Kimura S, Mari A, Briganti A, Remzi M, Seitz CK, Mathieu R, Karakiewicz PI, Shariat SF. Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy. Urol Oncol. 2018 Dec;36(12):528.e7-528.e13. doi: 10.1016/j.urolonc.2018.09.015. Epub 2018 Nov 13. PMID: 30446461.

43: Ferro M, Musi G, Serino A, Cozzi G, Mistretta FA, Costa B, Bianchi R, Cordima G, Luzzago S, Di Trapani E, Tagliabue E, Vartolomei MD, Terracciano D, Cassatella MC, Salvatici M, Conti A, Sandri MT, Cioffi A, Turetti M, Catellani M, Bottero D, Matei DV, Mirone V, de Cobelli O. Neutrophil, Platelets, and Eosinophil to Lymphocyte Ratios Predict Gleason Score Upgrading in Low-Risk Prostate Cancer Patients. Urol Int. 2019;102(1):43-50. doi: 10.1159/000494259. Epub 2018 Nov 8. PMID: 30408799.

44: Vartolomei MD, Matei DV, Renne G, Tringali VM, Crișan N, Musi G, Mistretta FA, Russo A, Conti A, Cozzi G, Luzzago S, Catellani M, Cioffi A, Cordima G, Bianchi R, Di Trapani E, Serino A, Delor M, Bianco R, Bottero D, Ferro M, De Cobelli O. Long-term oncologic and functional outcomes after robot-assisted partial nephrectomy in elderly patients. Minerva Urol Nefrol. 2019 Feb;71(1):31-37. doi: 10.23736/S0393-2249.18.03006-0. Epub 2018 Sep 19. PMID: 30230293.

45: Vartolomei L, Ferro M, Mirone V, Shariat SF, Vartolomei MD. Systematic Review: Depression and Anxiety Prevalence in Bladder Cancer Patients. Bladder Cancer. 2018 Jul 30;4(3):319-326. doi: 10.3233/BLC-180181. PMID: 30112443; PMCID: PMC6087432.

46: Kimura S, Mari A, Foerster B, Abufaraj M, Vartolomei MD, Stangl-Kremser J, Karakiewicz PI, Egawa S, Shariat SF. Prognostic Value of Concomitant Carcinoma In Situ in the Radical Cystectomy Specimen: A Systematic Review and Meta- Analysis. J Urol. 2019 Jan;201(1):46-53. doi: 10.1016/j.juro.2018.05.162. PMID: 30077559.

47: Vartolomei MD, Ferro M, Cantiello F, Lucarelli G, Di Stasi S, Hurle R, Guazzoni G, Busetto GM, De Berardinis E, Damiano R, Perdona S, Verze P, La Rocca R, Borghesi M, Schiavina R, Brunocilla E, Almeida GL, Bove P, Lima E, Grimaldi G, Autorino R, Crisan N, Abu Farhan AR, Battaglia M, Serretta V, Russo GI, Morgia G, Terracciano D, Musi G, de Cobelli O, Mirone V, Shariat SF. Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder Cancer. Clin Genitourin Cancer. 2018 Dec;16(6):445-452. doi: 10.1016/j.clgc.2018.07.003. Epub 2018 Jul 6. PMID: 30077463.

48: Kimura S, Soria F, D’Andrea D, Foerster B, Abufaraj M, Vartolomei MD, Karakiewicz PI, Mathieu R, Moschini M, Rink M, Egawa S, Shariat SF, Gust KM. Prognostic Value of Serum Cholinesterase in Non-muscle-invasive Bladder Cancer. Clin Genitourin Cancer. 2018 Dec;16(6):e1123-e1132. doi: 10.1016/j.clgc.2018.07.002. Epub 2018 Jul 6. PMID: 30061034.

49: Vartolomei MD, Kimura S, Vartolomei L, Shariat SF. Systematic Review of the Impact of Testosterone Replacement Therapy on Depression in Patients with Late-onset Testosterone Deficiency. Eur Urol Focus. 2020 Jan 15;6(1):170-177. doi:10.1016/j.euf.2018.07.006. Epub 2018 Jul 17. PMID: 30017901.

50: Ferro M, Vartolomei MD, Russo GI, Cantiello F, Farhan ARA, Terracciano D, Cimmino A, Di Stasi S, Musi G, Hurle R, Serretta V, Busetto GM, De Berardinis E, Cioffi A, Perdonà S, Borghesi M, Schiavina R, Cozzi G, Almeida GL, Bove P, Lima E, Grimaldi G, Matei DV, Crisan N, Muto M, Verze P, Battaglia M, Guazzoni G, Autorino R, Morgia G, Damiano R, de Cobelli O, Shariat S, Mirone V, Lucarelli G. An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer. World J Urol. 2019 Mar;37(3):507-514. doi: 10.1007/s00345-018-2397-1. Epub 2018 Jul 10. PMID: 29992381.

51: Ferro M, Vartolomei MD, Cantiello F, Lucarelli G, Di Stasi SM, Hurle R, Guazzoni G, Busetto GM, De Berardinis E, Damiano R, Perdonà S, Borghesi M, Schiavina R, Almeida GL, Bove P, Lima E, Grimaldi G, Autorino R, Crisan N, Abu Farhan AR, Verze P, Battaglia M, Serretta V, Russo GI, Morgia G, Musi G, de Cobelli O, Mirone V, Shariat SF. High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study. Urol Int. 2018;101(1):7-15. doi: 10.1159/000490765. Epub 2018 Jul 4. PMID: 29975950.

52: Cantiello F, Crocerossa F, Russo GI, Gangemi V, Ferro M, Vartolomei MD, Lucarelli G, Mirabelli M, Scafuro C, Ucciero G, De Cobelli O, Morgia G, Damiano R, Cascini GL. Comparison Between ⁶⁴Cu-PSMA-617 PET/CT and ¹⁸F-Choline PET/CT Imaging in Early Diagnosis of Prostate Cancer Biochemical Recurrence. Clin Genitourin Cancer. 2018 Oct;16(5):385-391. doi: 10.1016/j.clgc.2018.05.014. Epub 2018 Jun 4. PMID: 29937067.

53: Vartolomei MD, Porav-Hodade D, Ferro M, Mathieu R, Abufaraj M, Foerster B, Kimura S, Shariat SF. Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis. Urol Oncol. 2018 Sep;36(9):389-399. doi: 10.1016/j.urolonc.2018.05.014. Epub 2018 Jun 6. PMID: 29884342.

54: Vartolomei MD, Kimura S, Ferro M, Foerster B, Abufaraj M, Briganti A, Karakiewicz PI, Shariat SF. The impact of moderate wine consumption on the risk of developing prostate cancer. Clin Epidemiol. 2018 Apr 17;10:431-444. doi: 10.2147/CLEP.S163668. PMID: 29713200; PMCID: PMC5909789.

55: Balan D, Martha O, Chibelean CB, Tataru S, Voidezan S, Sin A, Matei VD, Vartolomei MD, Lucarelli G, Cioffi A, Del Giudice F, De Berardinis E, Borda A, Busetto GM, Ferro M, Pytel A, Porav-Hodade D. Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors. Medicine (Baltimore). 2018 Apr;97(16):e0522. doi: 10.1097/MD.0000000000010522. PMID: 29668641; PMCID: PMC5916673.

56: Porav-Hodade D, Martha O, Balan D, Tataru S, Hutanu A, Sin A, Vartolomei MD. Fascin is secreted in male’s serum: results of a pilot study. Future Sci OA. 2018 Jan 5;4(3):FSO273. doi: 10.4155/fsoa-2017-0098. PMID: 29568562; PMCID:PMC5859328.

57: Vince R, Hampton LJ, Vartolomei MD, Shariat SF, Porpiglia F, Autorino R. Robotic assisted simple prostatectomy: recent advances. Curr Opin Urol. 2018 May;28(3):309-314. doi: 10.1097/MOU.0000000000000499. PMID: 29528970.

58: Vartolomei MD, Kimura S, Ferro M, Vartolomei L, Foerster B, Abufaraj M, Shariat SF. Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients. World J Urol. 2018 Jul;36(7):1019-1029. doi: 10.1007/s00345-018-2235-5. Epub 2018 Feb 21. PMID: 29468284.

59: Foerster B, Kimura S, Vartolomei MD, Abufaraj M, Gust K, Fajkovic H, Shariat SF, Seitz C. Robot-assisted partial nephrectomy: systematic review of functional results. Curr Opin Urol. 2018 Mar;28(2):123-131. doi:10.1097/MOU.0000000000000482. PMID: 29278584.

60: Vartolomei MD, Foerster B, Kimura S, Autorino R, Shariat SF, Seitz C. Oncologic outcomes after minimally invasive surgery for cT1 renal masses: a comprehensive review. Curr Opin Urol. 2018 Mar;28(2):132-138. doi:  10.1097/MOU.0000000000000477. PMID: 29278581.

61: Vartolomei MD, Matei DV, Renne G, Tringali VM, Crisan N, Musi G, Mistretta FA, Russo A, Cozzi G, Cordima G, Luzzago S, Cioffi A, Di Trapani E, Catellani M, Delor M, Bottero D, Imbimbo C, Mirone V, Ferro M, de Cobelli O. Robot-assisted Partial Nephrectomy: 5-yr Oncological Outcomes at a Single European Tertiary Cancer Center. Eur Urol Focus. 2019 Jul;5(4):636-641. doi: 10.1016/j.euf.2017.10.005. Epub 2017 Oct 27. PMID: 29111154.

62: Matei DV, Zanagnolo V, Vartolomei MD, Crisan N, Ferro M, Bocciolone L, Maggioni A, Coman I, de Cobelli O. Robot-Assisted Vesico-Vaginal Fistula Repair: Our Technique and Review of the Literature. Urol Int. 2017;99(2):137-142. doi:10.1159/000475887. Epub 2017 Jul 26. PMID: 28743109.

63: Matei DV, Vartolomei MD, Musi G, Renne G, Tringali VML, Mistretta FA, Delor M, Russo A, Cioffi A, Bianchi R, Cozzi G, Di Trapani E, Bottero D, Cordima G, Lucarelli G, Ferro M, de Cobelli O. Outcomes of robot-assisted simple enucleation of renal masses: A single European center experience. Medicine (Baltimore). 2017 May;96(18):e6771. doi: 10.1097/MD.0000000000006771. PMID: 28471972; PMCID: PMC5419918.

64: Matei DV, Vartolomei MD, Renne G, Tringali VML, Russo A, Bianchi R, Cozzi G, Bottero D, Musi G, Mazzarol G, Ferro M, de Cobelli O. Reliability of Frozen Section Examination in a Large Cohort of Testicular Masses: What Did We Learn? Clin Genitourin Cancer. 2017 Aug;15(4):e689-e696. doi: 10.1016/j.clgc.2017.01.012. Epub 2017 Feb 1. PMID: 28216275.

65: Vidal A, Arnold N, Vartolomei MD, Kiss B, Burkhard F, Thalmann GN, Roth B. Oncological and functional outcomes of postoperative total parenteral nutrition after radical cystectomy in bladder cancer patients: A single-center randomized trial. Int J Urol. 2016 Dec;23(12):992-999. doi: 10.1111/iju.13228. Epub 2016 Oct 21. PMID: 27770454.

66: Vartolomei MD, Mathieu R, Margulis V, Karam JA, Rouprêt M, Lucca I, Mbeutcha A, Seitz C, Karakiewicz PI, Fajkovic H, Wood CG, Weizer AZ, Raman JD, Rioux-Leclercq N, Haitel A, Bensalah K, Rink M, Briganti A, Xylinas E, Shariat SF. Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy. World J Urol. 2017 Jan;35(1):121-130. doi: 10.1007/s00345-016-1848-9. Epub 2016 May 21. PMID: 27209168; PMCID: PMC5233730.

67: Morariu SH, Suciu M, Badea MA, Vartolomei MD, Buicu CF, Cotoi OS. Multiple asymptomatic cutaneous pilar leiomyoma versus spontaneous eruptive keloids – a case report. Rom J Morphol Embryol. 2016;57(1):283-7. PMID: 27151722.

68: Mathieu R, Vartolomei MD, Mbeutcha A, Karakiewicz PI, Briganti A, Roupret M, Shariat SF. Urothelial cancer of the upper urinary tract: emerging biomarkers and integrative models for risk stratification. Minerva Urol Nefrol. 2016 Aug;68(4):381-95. Epub 2016 Apr 28. PMID: 27124417.

69: Mathieu R, Lucca I, Vartolomei MD, Mbeutcha A, Klatte T, Seitz C, Karakiewicz PI, Fajkovic H, Sun M, Lotan Y, Montorsi F, Briganti A, Rouprêt M, Margulis V, Rink M, Rieken M, Kenner L, Susani M, Wolgang L, Shariat SF. Role of survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi-institutional study. BJU Int. 2017 Feb;119(2):234-238. doi: 10.1111/bju.13472. Epub 2016 Apr 5. PMID: 26940243.

70: Fajkovic H, Shariat SF, Klatte T, Vartolomei MD, Lucca I, Mbeutcha A, Rouprêt M, Briganti A, Karakiewicz PI, Margulis V, Rink M, Remzi M, Seitz C, Bensalah K, Mathieu R. Impact of smoking status on survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. World J Urol. 2016 Oct;34(10):1411-9. doi: 10.1007/s00345-016-1767-9. Epub 2016 Feb 15. PMID: 26879416.

71: Vartolomei MD, Cotoi OS, Badea MA, Chibelean CB, Cotoi T, Morariu V, Albu C, Morariu SH. Indurative Edema of the Prepuce Mimicing Phimosis, an Atypical Manifestation of Primary Syphilis. Acta Dermatovenerol Croat. 2015;23(4):301-3. PMID: 26724885.

72: Ormenişan A, Morariu SH, Cotoi OS, Vartolomei MD, Grigoraş RI, Mocan SL, Suciu M. Necrotizing fasciitis in oro-maxillo-facial area after radiotherapy for squamous cell carcinoma of the soft palate. Rom J Morphol Embryol. 2015;56(2 Suppl):847-50. PMID: 26429184.

73: Vartolomei MD, Kiss B, Vidal A, Burkhard F, Thalmann GN, Roth B. Long-term results of a prospective randomized trial assessing the impact of re-adaptation of the dorsolateral peritoneal layer after extended pelvic lymph node dissection and cystectomy. BJU Int. 2016 Apr;117(4):618-28. doi: 10.1111/bju.13178. Epub 2015 Jun 25. PMID: 25959738.

74: Cotoi OS, Mureşan AV, Tilinca MC, Chiotoroiu AL, Badea MA, Vartolomei MD, Suciu M, Morariu SH. Giant dermatofibrosarcoma protuberans – rare form of mesenchymal tissue neoplasm: case presentation. Rom J Morphol Embryol. 2014;55(4):1491-5. PMID: 25611287.

 75: Morariu SH, Rotaru M, Vartolomei MD, Turcu M, Chiotoroiu AL, Suciu M, Cotoi OS. Pagetoid reticulosis Woringer-Kolopp type, a particular variant of mycosis fungoides: a case report. Rom J Morphol Embryol. 2014;55(4):1469-72. PMID: 25611283.

76: Suciu M, Morariu SH, Ormenişan A, Grigoraş RI, Bostan RH, Mocanu S, Vartolomei MD, Cotoi OS. Oral squamous cell carcinoma of the maxilla, a second malignancy after a right ethmoido-maxillary chondrosarcoma. Rom J Morphol Embryol. 2014;55(3 Suppl):1247-51. PMID: 25607415.

77: Morariu SH, Suciu M, Vartolomei MD, Badea MA, Cotoi OS. Aneurysmal dermatofibroma mimicking both clinical and dermoscopic malignant melanoma and Kaposi’s sarcoma. Rom J Morphol Embryol. 2014;55(3 Suppl):1221-4. PMID: 25607410.